VERA (Vera Therapeutics, Inc. Class A Common Stock) Stock Analysis - Financials
Vera Therapeutics, Inc. Class A Common Stock (VERA) is a publicly traded Healthcare sector company. As of May 21, 2026, VERA trades at $34.67 with a market cap of $2.47B and a P/E ratio of -7.31. VERA moved +4.15% today. Year to date, VERA is -26.45%; over the trailing twelve months it is +62.99%. Its 52-week range spans $18.53 to $56.05. Analyst consensus is strong buy with an average price target of $77.67. Rallies surfaces VERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are VERA's key financials?
VERA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VERA recently traded at $34.67. Market cap is $2.47B. P/E ratio is -7.31. Revenue is $0.
VERA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VERA recently traded at $34.67. Market cap is $2.47B. P/E ratio is -7.31. Revenue is $0.
Is VERA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VERA. It does not provide personalized investment advice.